Patents by Inventor Michael Mann

Michael Mann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11954495
    Abstract: To accelerate the data processing of a processor, a coprocessor subsystem can be used to offload data processing operations from the processor. The coprocessor subsystem can include a coprocessor and an accelerator. The accelerator can offload operations such as data formatting operations from the coprocessor to improve the performance of the coprocessor. The coprocessor subsystem can be used to accelerate database operations.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: April 9, 2024
    Assignee: Amazon Technologies, Inc.
    Inventors: Michael Shteinbok, Yaniv Halmut, Jonathan Cohen, Nofar Mann, Tamir Malka, Amit Abecasis, Assaf Fainer
  • Publication number: 20240091806
    Abstract: A dispenser for dispensing materials includes a dispenser body, a driving rod movable relative to the dispenser body and into the receptacle, a trigger lever having an actuation member for displacing the driving rod upon rotation of the trigger lever around a rotation axis, and a pivot member that rotatably connects the trigger lever to the dispenser body and defines the rotation axis. The pivot member is movably connected to the trigger lever such that a lever distance between the rotation axis and the actuation member changes upon movement of the pivot member relative to the trigger lever. The dispenser includes an adjustment mechanism for adjusting a mechanical advantage of the trigger lever by changing the lever distance and to adjustably fix the lever distance to at least a minimum distance and a maximum distance.
    Type: Application
    Filed: January 18, 2022
    Publication date: March 21, 2024
    Inventors: Mark TINKLER, Matt LYNDON, Michael MANN
  • Publication number: 20230150942
    Abstract: The present disclosure provides compounds, pharmaceutical compositions, and methods for the treatment of cancer and fibrosis. The disclosed pharmaceutical compositions may include one or more pyrazolyl-containing compounds, or a derivative thereof.
    Type: Application
    Filed: December 5, 2022
    Publication date: May 18, 2023
    Inventors: Csaba PETO, Bhairavi TOLANI, Gavitt WOODARD, Tsze TSANG, Michael MANN, David M. JABLONS, Biao HE
  • Publication number: 20230086892
    Abstract: Various embodiments include a thermal storage system for storing energy in a graphite thermal storage structure and a thermal shutter assembly configured to control the transmission of heat from the graphite thermal storage structure to a thermal energy receiver, such as a heat exchanger or material processing crucible. A thermal storage block, which may be made of graphite, may be isolated by insulation except for the thermal shutter assembly. Energy may be stored in the graphite thermal storage block by applying energy to the block to raise its temperature to maximum operation temperature. Stored energy may then be harvested in a controlled manner by a control system actuating the thermal shutter to expose the thermal energy receiver to thermal radiation.
    Type: Application
    Filed: August 31, 2022
    Publication date: March 23, 2023
    Inventors: Andrew Cameron ROBERTSON, Harold Edwin DITTMER, Gary Alan FRANZEN, Timothy Michael MANN
  • Patent number: 11560356
    Abstract: The present disclosure provides compounds, pharmaceutical compositions, and methods for the treatment of cancer and fibrosis. The disclosed pharmaceutical compositions may include one or more pyrazolyl-containing compounds, or a derivative thereof.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: January 24, 2023
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, RESCUE THERAPEUTICS, INC.
    Inventors: Csaba Peto, Bhairavi Tolani, Gavitt Woodard, Tsze Tsang, Michael Mann, David M. Jablons, Biao He
  • Publication number: 20210009523
    Abstract: The present disclosure provides compounds, pharmaceutical compositions, and methods for the treatment of cancer and fibrosis. The disclosed pharmaceutical compositions may include one or more pyrazolyl-containing compounds, or a derivative thereof.
    Type: Application
    Filed: June 28, 2017
    Publication date: January 14, 2021
    Inventors: Csaba Peto, Bhairavi Tolani, Gavitt Woodard, Tsze Tsang, Michael Mann, David M. Jablons, Biao He
  • Patent number: 10787341
    Abstract: Elevator control system, comprising an elevator control device for operating an elevator car which is adapted to be operated within an elevator shaft, and an inspection control station configured to communicate with the elevator control device for operating at least one function of an elevator system in an inspection or maintenance operation mode, and configured for attachment at a storing location, wherein the storing location is at the elevator car or within the elevator shaft or in proximity of the elevator shaft. The inspection control station is adapted to be detachable from the storing location and configured to operate as remote inspection control station when detached from the storing location through wireless communication with the elevator control device, and is configured to be movable and operable in the inspection or maintenance operation mode from inside and outside of the elevator car and within the elevator shaft.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: September 29, 2020
    Assignee: OTIS ELEVATOR COMPANY
    Inventors: Peter Herkel, Michael Mann, Helmut Lothar Schroeder-Brumloop, Pascal Rebillard, Igor Kuzmin
  • Patent number: 10720291
    Abstract: A switch including a housing, a first contact arrangement having a first commutation contact element and a first contact, a second contact arrangement having a second commutation contact element and a second contact, and also a nominal contact arrangement. The first commutation contact element and the second commutation contact element form a snap-action connection with one another in the closed position of the commutation contact element. When the switch is closed, a distance between the first contact and the second contact is smaller than a distance between the first commutation contact element and the second commutation contact element in the direction of the axis.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: July 21, 2020
    Assignee: ABB Power Grids Switzerland AG
    Inventors: Hauke Peters, Horst Schalber, Michael Mann, Ralph Uhl
  • Patent number: 10641780
    Abstract: The present disclosure provides methods and compositions that find use in facilitating a diagnosis of inflammatory liver disease in a subject. The methods and compositions generally involve detection of eotaxin-3 (E3) levels, either alone or with levels of eotaxin-1 (E1), and optionally, with levels of CCL22 and, further optionally, with levels of IL15. These levels can be used to facilitate a diagnosis of a liver disease of at least one of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC), and/or to facilitate a differential diagnosis between AIH, PBC, and PSC. The methods and compositions of the present disclosure also find use in facilitating treatment decisions for a subject.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: May 5, 2020
    Assignees: The Governors of the University of Alberta, Medizinische Hochschule Hannover
    Inventors: Abdolamir Landi, Michael Houghton, D. Lorne Tyrrell, Tim Lankisch, Tobias Weismueller, Michael Manns
  • Publication number: 20190198272
    Abstract: A switch including a housing, a first contact arrangement having a first commutation contact element and a first contact, a second contact arrangement having a second commutation contact element and a second contact, and also a nominal contact arrangement. The first commutation contact element and the second commutation contact element form a snap-action connection with one another in the closed position of the commutation contact element. When the switch is closed, a distance between the first contact and the second contact is smaller than a distance between the first commutation contact element and the second commutation contact element in the direction of the axis.
    Type: Application
    Filed: February 26, 2019
    Publication date: June 27, 2019
    Inventors: Hauke Peters, Horst Schalber, Michael Mann, Ralph Uhl
  • Publication number: 20180209992
    Abstract: The present disclosure provides methods and compositions that find use in facilitating a diagnosis of inflammatory liver disease in a subject. The methods and compositions generally involve detection of eotaxin-3 (E3) levels, either alone or with levels of eotaxin-1 (E1), and optionally, with levels of CCL22 and, further optionally, with levels of IL15. These levels can be used to facilitate a diagnosis of a liver disease of at least one of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC), and/or to facilitate a differential diagnosis between AIH, PBC, and PSC. The methods and compositions of the present disclosure also find use in facilitating treatment decisions for a subject.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 26, 2018
    Inventors: Abdolamir Landi, Michael Houghton, D. Lorne Tyrrell, Tim Lankisch, Tobias Weismueller, Michael Manns
  • Publication number: 20180186602
    Abstract: The present disclosure relates to an elevator control system (1), comprising an elevator control device (2) for operating an elevator car (12) which is adapted to be operated within an elevator shaft (18), and an inspection control station (3) configured to communicate with the elevator control device (2) for operating at least one function of an elevator system (10) in an inspection or maintenance operation mode, and configured for attachment at a storing location (71,72) of the elevator system (10), wherein the storing location (71,72) is at the elevator car (12) or within the elevator shaft (18) or in proximity of the elevator shaft (18).
    Type: Application
    Filed: July 1, 2015
    Publication date: July 5, 2018
    Inventors: Peter Herkel, Michael Mann, Helmut Lothar Schroeder-Brumloop, Pascal Rebillard, Igor Kuzmin
  • Patent number: 9952226
    Abstract: The present disclosure provides methods and compositions that find use in facilitating a diagnosis of inflammatory liver disease in a subject. The methods and compositions generally involve detection of eotaxin-3 (E3) levels, either alone or with levels of eotaxin-1 (E1), and optionally, with levels of CCL22 and, further optionally, with levels of IL15. These levels can be used to facilitate a diagnosis of a liver disease of at least one of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC), and/or to facilitate a differential diagnosis between AIH, PBC, and PSC. The methods and compositions of the present disclosure also find use in facilitating treatment decisions for a subject.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: April 24, 2018
    Assignees: Medizinische Hochschule Hannover, The Governors of the University of Alberta
    Inventors: Abdolamir Landi, Michael Houghton, D. Lorne Tyrrell, Tim Lankisch, Tobias Weismueller, Michael Manns
  • Patent number: 9914617
    Abstract: A system for managing elevator power includes a power line connected to a power grid, a motor connected to the power line and configured to receive power from the power line to drive an elevator, an alternative power source connected to the motor, and a power control system configured to control the power line to supply power to the motor to drive the elevator, to detect a predetermined threshold value of power supplied from the power line, and to supply both power from the power line and power from the alternative power source to the motor based on a determination that the predetermined threshold value of power is supplied from the power line.
    Type: Grant
    Filed: July 18, 2012
    Date of Patent: March 13, 2018
    Assignee: OTIS ELEVATOR COMPANY
    Inventors: Herbert Horbrügger, Michael Mann, Dirk H. Tegtmeier
  • Patent number: 9840470
    Abstract: The present disclosure provides compositions, pharmaceutical preparations and methods for the diagnosis and treatment of cancers expressing a GLI polypeptide. The disclosed compositions and pharmaceutical preparations may comprise one or more pyrazolyl-containing compounds, or an analog or derivative thereof.
    Type: Grant
    Filed: January 22, 2014
    Date of Patent: December 12, 2017
    Assignee: The Regents of the University of California
    Inventors: Biao He, Michael Mann, David M. Jablons
  • Publication number: 20170153251
    Abstract: The present disclosure provides methods and compositions that find use in facilitating a diagnosis of inflammatory liver disease in a subject. The methods and compositions generally involve detection of eotaxin-3 (E3) levels, either alone or with levels of eotaxin-1 (E1), and optionally, with levels of CCL22 and, further optionally, with levels of IL15. These levels can be used to facilitate a diagnosis of a liver disease of at least one of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC), and/or to facilitate a differential diagnosis between AIH, PBC, and PSC. The methods and compositions of the present disclosure also find use in facilitating treatment decisions for a subject.
    Type: Application
    Filed: November 21, 2016
    Publication date: June 1, 2017
    Inventors: Abdolamir Landi, Michael Houghton, D. Lorne Tyrrell, Tim Lankisch, Tobias Weismueller, Michael Manns
  • Patent number: 9608988
    Abstract: Methods and systems for authenticating a security device for providing a secure access and transaction authorization to a remote network location are provided. The security device is authenticated by installing private security software on the security device. In order to authorize a transaction, a transaction authorization is performed using the security device by display a QR (Quick Response) code from an authorization server on a user terminal and scanning the QR code into the security device. After scanning the QR code, an OTA (One-Time-Authorization) code is sent from the security device to the authorization server for verifying the transaction. Embodiments of the present invention provide increased security and privacy. A corresponding system for authenticating a security device and preforming secure and private transactions is also provided.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: March 28, 2017
    Assignee: INBAY TECHNOLOGIES INC.
    Inventors: Randy Kuang, Stanislus Kisito Xavier, David Michael Mann, He Zhu, Yiwen Wang, Yuebin Ding
  • Patent number: 9548978
    Abstract: Methods and systems for authenticating a security device for providing a secure access and transaction authorization to a remote network location are provided. The security device is authenticated by installing private security software on the security device. A Two-Channel authorization method includes a transaction notification/authorization channel and a transaction channel. A Three-Channel authorization method includes a transaction notification channel, a transaction authorization channel, and the transaction channel. Embodiments of the present invention provide increased security and privacy. A corresponding system for authenticating a security device and preforming secure private transactions is also provided.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: January 17, 2017
    Inventors: Randy Kuang, Stanislus Kisito Xavier, David Michael Mann, He Zhu, Yiwen Wang, Yuebin Ding
  • Patent number: 9535071
    Abstract: The present disclosure provides methods and compositions that find use in facilitating a diagnosis of inflammatory liver disease in a subject. The methods and compositions generally involve detection of eotaxin-3 (E3) levels, either alone or with levels of eotaxin-1 (E1), and optionally, with levels of CCL22 and, further optionally, with levels of IL15. These levels can be used to facilitate a diagnosis of a liver disease of at least one of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC), and/or to facilitate a differential diagnosis between AIH, PBC, and PSC. The methods and compositions of the present disclosure also find use in facilitating treatment decisions for a subject.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: January 3, 2017
    Assignees: The Governors of the University of Alberta, Medizinische Hochschule Hannover
    Inventors: Abdolamir Landi, Michael Houghton, D. Lorne Tyrrell, Tim Lankisch, Tobias Weismueller, Michael Manns
  • Patent number: 9485254
    Abstract: Methods for authenticating a security device at a local network location for providing a secure access from the local network location to a remote network location are provided. A security device is registered by installing private security software on the security device that generates an asymmetrical encryption key pair including an encryption key and a decryption key. The encryption key is stored only on the security device and the decryption key is stored only on a remote server. Embodiments of the present invention provide increased security by not storing the encryption key on the remote server so that attackers stealing data from the server cannot pretend to a user having the registered security device. A corresponding system for authenticating a security device is also provided.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: November 1, 2016
    Assignee: INBAY TECHNOLOGIES INC.
    Inventors: Randy Kuang, Stanislus Kisito Xavier, David Michael Mann, Robert Frank Steklasa, Stephen George Wilson, He Zhu, Nicolas Johannes Sebastian Bettenburg